Attitudes Toward a Potential SARS-CoV-2 Vaccine

Kimberly A. Fisher; Sarah J. Bloomstone; Jeremy Walder; Sybil L. Crawford; Hassan Fouayzi; Kathleen M. Mazor

doi:10.7326/m20-3569

Abstract

Agency for Healthcare Research and Quality.

Keywords

MedicinePandemicCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyCoronavirusPaceDiseaseOutbreakInfectious disease (medical specialty)Internal medicine

Affiliated Institutions

University of Massachusetts Chan Medical School US

Related Publications

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

SARS-CoV-2 vaccines in development

Florian Krammer

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in late 2019 in China and is the causative agent of the coronavirus disease 2019 (COVID-19) pande...

2020 Nature 2193 citations

Covid-19 Breakthrough Infections in Vaccinated Health Care Workers

Moriah Bergwerk , Tal Gonen , Yaniv Lustig +13 more

To assess the effectiveness of the BNT162b2 vaccine among health care workers and to examine possible correlates of protection and infectivity

2021 New England Journal of Medicine 1451 citations

Global impact of the first year of COVID-19 vaccination: a mathematical modelling study

Oliver J. Watson , Gregory Barnsley , Jaspreet Toor +3 more

The first COVID-19 vaccine outside a clinical trial setting was administered on Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 Vaccines G...

2022 The Lancet Infectious Diseases 1707 citations

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data

Eric J. Haas , Frederick J. Angulo , John M. McLaughlin +12 more

Following the emergency use authorisation of the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 (international non-proprietary name tozinameran) in Israel, the Ministry of Healt...

2021 The Lancet 1722 citations

Publication Info

Year: 2020
Type: editorial
Volume: 173
Issue: 12
Pages: 964-973
Citations: 1201
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Attitudes Toward a Potential SARS-CoV-2 Vaccine

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1201

OpenAlex

Cite This

APA Style

                            
                                
                                    Kimberly A. Fisher, 
                                
                                    Sarah J. Bloomstone, 
                                
                                    Jeremy Walder
                                
                                et al.
                            
                            (2020). 
                            Attitudes Toward a Potential SARS-CoV-2 Vaccine. 
                            Annals of Internal Medicine
                            , 173
                            (12)
                            , 964-973.
                            https://doi.org/10.7326/m20-3569
                        

Identifiers

DOI: 10.7326/m20-3569